Cargando…

Comparative Performance of Creatinine-Based GFR Estimation Equations in Exceptional Longevity: The Rugao Longevity and Ageing Study

PURPOSE: Reduced kidney function has been associated with an increased risk for adverse outcomes. Accurate assessment of glomerular filtration rate (GFR) is key to diagnosis and management of kidney disfunction. Debate exists on the best GFR estimation equation for elderly people. This study aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mengjing, Sun, Xuehui, Ni, Li, Zhang, Minmin, Zhang, Jiaying, Ye, Guoxin, Jin, Li, Wang, Xiaofeng, Chen, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266309/
https://www.ncbi.nlm.nih.gov/pubmed/32546991
http://dx.doi.org/10.2147/CIA.S250535
_version_ 1783541282573910016
author Wang, Mengjing
Sun, Xuehui
Ni, Li
Zhang, Minmin
Zhang, Jiaying
Ye, Guoxin
Jin, Li
Wang, Xiaofeng
Chen, Jing
author_facet Wang, Mengjing
Sun, Xuehui
Ni, Li
Zhang, Minmin
Zhang, Jiaying
Ye, Guoxin
Jin, Li
Wang, Xiaofeng
Chen, Jing
author_sort Wang, Mengjing
collection PubMed
description PURPOSE: Reduced kidney function has been associated with an increased risk for adverse outcomes. Accurate assessment of glomerular filtration rate (GFR) is key to diagnosis and management of kidney disfunction. Debate exists on the best GFR estimation equation for elderly people. This study aimed to compare the predictive validity and discriminative ability of four GFR equations in relation to 2-year and 6-year mortality in exceptional longevity (EL) (those over 95 years old with intact health) individuals and is an ideal model to address factors relating to life span and age-related diseases. PATIENTS AND METHODS: This study used 6 years’ data of 278 EL from the Rugao longevity cohort. Baseline GFR was estimated using four equations: Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation, Modification of Diet in Renal Disease Study (MDRD) equation, Berlin Initiative Study-1 (BIS) equation, and modified MDRD equation. Predictive validity was tested using Cox proportional hazards analysis. Overall improvement in reclassification based on estimated GFR (eGFR) was assessed applying net reclassification improvement (NRI). RESULTS: Mean age of participants was 97±2 years with median follow-up of 2.6 years. Median (IQR) eGFR by CKD-EPI, MDRD, BIS, and modified MDRD equations were 73.9 (62.2–77.6), 82.3 (67.4–98.6), 56.4 (47.9–63.9), and 101.5 (83.1–121.6) mL/min per 1.73 m(2), respectively. Higher eGFR(EPI) was associated with lower mortality after multivariate adjustment (for continuous eGFR(EPI), HR(two-year) 1.018, 95% CI 1.002–1.033, P=0.023; HR(six-year) 1.013, 95% CI 1.002–1.025, P=0.022), while eGFR from other equations did not show any associations with mortality. NRI for two-year mortality was 0.14 and approximately significant, which may favor the CKD-EPI when compared to BIS equation (P=0.052). CONCLUSION: The CKD-EPI equation showed more accurate estimation of kidney function in the elderly with respect to GFR distribution and predictability of mortality risk.
format Online
Article
Text
id pubmed-7266309
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-72663092020-06-15 Comparative Performance of Creatinine-Based GFR Estimation Equations in Exceptional Longevity: The Rugao Longevity and Ageing Study Wang, Mengjing Sun, Xuehui Ni, Li Zhang, Minmin Zhang, Jiaying Ye, Guoxin Jin, Li Wang, Xiaofeng Chen, Jing Clin Interv Aging Original Research PURPOSE: Reduced kidney function has been associated with an increased risk for adverse outcomes. Accurate assessment of glomerular filtration rate (GFR) is key to diagnosis and management of kidney disfunction. Debate exists on the best GFR estimation equation for elderly people. This study aimed to compare the predictive validity and discriminative ability of four GFR equations in relation to 2-year and 6-year mortality in exceptional longevity (EL) (those over 95 years old with intact health) individuals and is an ideal model to address factors relating to life span and age-related diseases. PATIENTS AND METHODS: This study used 6 years’ data of 278 EL from the Rugao longevity cohort. Baseline GFR was estimated using four equations: Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation, Modification of Diet in Renal Disease Study (MDRD) equation, Berlin Initiative Study-1 (BIS) equation, and modified MDRD equation. Predictive validity was tested using Cox proportional hazards analysis. Overall improvement in reclassification based on estimated GFR (eGFR) was assessed applying net reclassification improvement (NRI). RESULTS: Mean age of participants was 97±2 years with median follow-up of 2.6 years. Median (IQR) eGFR by CKD-EPI, MDRD, BIS, and modified MDRD equations were 73.9 (62.2–77.6), 82.3 (67.4–98.6), 56.4 (47.9–63.9), and 101.5 (83.1–121.6) mL/min per 1.73 m(2), respectively. Higher eGFR(EPI) was associated with lower mortality after multivariate adjustment (for continuous eGFR(EPI), HR(two-year) 1.018, 95% CI 1.002–1.033, P=0.023; HR(six-year) 1.013, 95% CI 1.002–1.025, P=0.022), while eGFR from other equations did not show any associations with mortality. NRI for two-year mortality was 0.14 and approximately significant, which may favor the CKD-EPI when compared to BIS equation (P=0.052). CONCLUSION: The CKD-EPI equation showed more accurate estimation of kidney function in the elderly with respect to GFR distribution and predictability of mortality risk. Dove 2020-05-26 /pmc/articles/PMC7266309/ /pubmed/32546991 http://dx.doi.org/10.2147/CIA.S250535 Text en © 2020 Wang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wang, Mengjing
Sun, Xuehui
Ni, Li
Zhang, Minmin
Zhang, Jiaying
Ye, Guoxin
Jin, Li
Wang, Xiaofeng
Chen, Jing
Comparative Performance of Creatinine-Based GFR Estimation Equations in Exceptional Longevity: The Rugao Longevity and Ageing Study
title Comparative Performance of Creatinine-Based GFR Estimation Equations in Exceptional Longevity: The Rugao Longevity and Ageing Study
title_full Comparative Performance of Creatinine-Based GFR Estimation Equations in Exceptional Longevity: The Rugao Longevity and Ageing Study
title_fullStr Comparative Performance of Creatinine-Based GFR Estimation Equations in Exceptional Longevity: The Rugao Longevity and Ageing Study
title_full_unstemmed Comparative Performance of Creatinine-Based GFR Estimation Equations in Exceptional Longevity: The Rugao Longevity and Ageing Study
title_short Comparative Performance of Creatinine-Based GFR Estimation Equations in Exceptional Longevity: The Rugao Longevity and Ageing Study
title_sort comparative performance of creatinine-based gfr estimation equations in exceptional longevity: the rugao longevity and ageing study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266309/
https://www.ncbi.nlm.nih.gov/pubmed/32546991
http://dx.doi.org/10.2147/CIA.S250535
work_keys_str_mv AT wangmengjing comparativeperformanceofcreatininebasedgfrestimationequationsinexceptionallongevitytherugaolongevityandageingstudy
AT sunxuehui comparativeperformanceofcreatininebasedgfrestimationequationsinexceptionallongevitytherugaolongevityandageingstudy
AT nili comparativeperformanceofcreatininebasedgfrestimationequationsinexceptionallongevitytherugaolongevityandageingstudy
AT zhangminmin comparativeperformanceofcreatininebasedgfrestimationequationsinexceptionallongevitytherugaolongevityandageingstudy
AT zhangjiaying comparativeperformanceofcreatininebasedgfrestimationequationsinexceptionallongevitytherugaolongevityandageingstudy
AT yeguoxin comparativeperformanceofcreatininebasedgfrestimationequationsinexceptionallongevitytherugaolongevityandageingstudy
AT jinli comparativeperformanceofcreatininebasedgfrestimationequationsinexceptionallongevitytherugaolongevityandageingstudy
AT wangxiaofeng comparativeperformanceofcreatininebasedgfrestimationequationsinexceptionallongevitytherugaolongevityandageingstudy
AT chenjing comparativeperformanceofcreatininebasedgfrestimationequationsinexceptionallongevitytherugaolongevityandageingstudy